Antigenaemia and antibody response to Toxoplasma gondii in human immunodeficiency virus-infected patients

British Journal of Biomedical Science

Volumn 62, Issue 1, 2005, Pages 19-23

  Malla, Nancy ^a   Sengupta, C ^a   Dubey, M L ^a   Sud, A ^a   Dutta, U ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Antibodies; Antigens; HIV; Toxoplasma gondii

Indexed keywords

ANTIBODY; ANTIGEN; CD4 ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; TOXOPLASMA ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ANTIGEN DETECTION; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; TOXOPLASMA; TOXOPLASMA GONDII;

EID: 16444382690     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2005.11732682     Document Type: Article

References (24)

1. Anthony SF, Clifford LH. Human immunodeficiency virus (HIV) disease: AIDS and related disorders. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martine JB, Kasper DL, eds. Harrison's Principles of Internal Medicine (14th edn). New York: McGraw Hill, 1998: 1791-856.
2. Luft BJ, Remington JS. Toxoplasmic encephalitis. J Infect Dis 1988; 157(1): 1-6.
3. Canh P, Belloso WH, Murillo J, Prada-Trujillo G. AIDS in Latin America. Infect Dis Clin North Am 2000; 14: 185-209.
4. Guimaraes ACS, Kawarabayashi M, Borges MM, Tolezano JE, Andrade Jr II F. Regional variation in toxoplasmosis seronegativity in the Sao Paulo metropolitan region. Revista do Instituto de Medicina Tropical de Sao Paulo 1993; 35: 479-83.
5. Wanke C, Tuazon CU, Kovacs A et al. Toxoplasma encephalitis in patients with acquired immune deficiency syndrome: diagnosis and response to therapy. Am J Trop Med Hyg 1987; 36: 509-16.
6. National AIDS Control Organization. Epidemiology of HIV/AIDS. In: Rewari BB, ed. Specialists' Training and Reference Module, New Delhi: National AIDS Control Organization, 1999: 1-11.
7. Bhatia VN, Menakshi K, Madhuvan AN, Agarwal SC. Toxoplasmosis in south India - serological study. Indian J Med Res 1974; 62: 1818.
8. Mahajan RC, Chitkara NL, Jolly JG. Serological survey of toxoplasma antibodies in Chandigarh area (Northern India). Indian J Med Res 1974; 62: 1-6.
9. Thokar MA, Malla N, Wattal C. Serological study of patients clinically suspected to have toxoplasmosis in Kashmir. Indian J Med Res 1988; 88: 29-34.
10. Singh S, Nautiyal BL. Seroprevalence of toxoplasmosis in Kumaon regions of India. Indian J Med Res 1991; 93: 247-9.
11. Sharma P, Gupta I, Ganguly NK, Mahajan RC, Malla N. Increasing toxoplasma seropositivity in women with bad obstetric history and in newborns. Nat Med J India 1997; 10: 65-6.
12. Meisheri YV, Mehta S, Patel U. A prospective study of seroprevalence of toxoplasmosis in general population and in HIV/AIDS patients in Bombay. Indian J Postgrad Med 1997; 43: 93-7.
13. Wadia RS, Pujari SN, Kothari S et al. Neurological manifestations of HIV disease. J Assoc Physicians India 2001; 49: 343-8.
14. Carr A, Tindall B, Brew BJ et al. Low dose trimethoprim -sulphamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Ann Intern Med 1992; 117: 106-11.
15. Centers for Disease Control and Prevention. Update: trends in AIDS diagnosis and reporting under the expanded surveillance definition for adolescents and adults - United States, 1993. Mort Morb Week Rep 1994; 43: 826.
16. Lowry DH, Resenbrough NJ, Farr AL, Randall RJ. Protein measurement with Polin phenol reagent. J Biol Chem 1951; 193: 265-75.
17. Voller A, Bidwell DE, Barlett A. Enzyme immunoassays in diagnostic medicine - theory and practice. Bull WHO 1976; 53: 55-65.
18. Antibody purification. In: Maizels RM, Baxter ML, Robertson BD et al., eds. Parasite antigens and parasite genes. A laboratory manual for molecular parasitology Cambridge: University Press, 1991: 79.
19. Julander I, Martin C, Lappalainen M, Guy E, Isberg B, Evengard B. Polymerase chain reaction for diagnosis of cerebral toxoplasmosis in cerebrospinal fluid in HIV-positive patients. Scand J Infect Dis 2001; 33: 538-41.
20. Alonso R, Martinez E, Laynez P, Miguelez M, Pinero JE, Valladares B. Detection by nested-PCR of Toxoplasma gondii in patients infected with human immunodeficiency virus. Med Clin (Barc) 2002; 118: 294-6.
21. Contini C, Cultrera R, Seraceni S et al. The role of stage-specific oligonucleotide primers in providing effective laboratory support for the molecular diagnosis of reactivated Toxoplasma gondii encephalitis in patients with AIDS. J Med Microbiol 2002; 51: 879-90.
22. Weiss LM, Stephen A Udem, Tonowitz H, Wittner M. Western blot analysis of the antibody response of patients with AIDS and toxoplasma encephalitis: antigenic diversity among toxoplasma strains. J Infect Dis 1988; 157: 7-13.
23. Nissapatorn V, Lee CK, Khairul AA. Seroprevalence of toxoplasmosis among AIDS patients in Hospital Kuala Lumpur. Singapore Med J 2003; 44: 194-6.
24. Malla N, Sengupta C, Dubey ML, Sud A, Ansari NA, Salotra P. Antigenaemia and antibody response to Leishmania donovani stage-specific antigens and rk39 antigen in human immunodeficiency virus-infected patients. Br J Biomed Sci 2003; 60: 210-6.